EVOLUÇÃO DAS INDICAÇÕES PARA O TRATAMENTO MEDICAMENTOSO DA DEGENERAÇÃO MACULAR RELACIONADA À IDADE NA FORMA ÚMIDA ENTRE 2018 E 2025
Mohamed Zahwe, Roberto Augusto Fernandes Machado · 2026
Read EVOLUÇÃO DAS INDICAÇÕES PARA O TRATAMENTO MEDICAMENTOSO DA DEGENERAÇÃO MACULAR RELACIONADA À IDADE NA FORMA ÚMIDA ENTRE 2018 E 2025 by Mohamed Zahwe, Roberto Augusto Fernandes Machado (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w7205012761.txt.
Description
Mohamed Zahwe and Roberto Augusto Fernandes Machado track how drug treatment for wet age-related macular degeneration changed in the Brazilian state of Parana between 2018 and 2025. Wet macular degeneration is a major cause of lasting vision loss in older adults. Working from national health system records, the authors count more than one hundred thousand retinal drug treatment records over the period.
Their time-series study finds a sharp rise in treatment, with yearly procedures climbing from under two thousand in 2021 to nearly thirty-six thousand in 2025. Part of that jump came from a 2022 rule change that widened the billing code to cover swelling linked to diabetic eye disease and lowered its minimum age. Because of that change, the authors warn, not every record can be credited to wet macular degeneration alone.
Catalog record
| CREATOR | Mohamed Zahwe, Roberto Augusto Fernandes Machado |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | OpenAlex / Revista Ibero-Americana de Humanidades, Ciências e Educação |